Nieuwdorp, Max

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 3,708

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 2,913

European consensus conference on faecal microbiota transplantation in clinical practice

Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 1,207

Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition

Kootte, R. S., Levin, E., Salojärvi, J., Smits, L. P., Hartstra, A. V., Udayappan, S. D., Hermes, G., Bouter, K. E., Koopen, A. M., Holst, J. J., et al. (2017) · Cell Metabolism

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 1,039

Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1

Koh, A., Molinaro, A., Ståhlman, M., Khan, M. T., Schmidt, C., Mannerås-Holm, L., Wu, H., Carreras, A., Jeong, H., Olofsson, L. E., et al. (2018) · Cell

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 824

Therapeutic Potential of Fecal Microbiota Transplantation

Smits, L. P., Bouter, K. E. C., de Vos, W. M., Borody, T. J., & Nieuwdorp, M. (2013) · Gastroenterology

Gut microbiota and healthClostridium difficile and Clostridium perfringens research

Cited by 717

Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography

Deschasaux, M., Bouter, K. E., Prodan, A., Levin, E., Groen, A. K., Herrema, H., Tremaroli, V., Bakker, G. J., Attaye, I., Pinto-Sietsma, S.-J., et al. (2018) · Nature Medicine

Gut microbiota and healthOral microbiology and periodontitis research

Cited by 695

Insights into the role of the microbiome in obesity and type 2 diabetes

Hartstra, A. V., Bouter, K. E. C., Bäckhed, F., & Nieuwdorp, M. (2015) · Diabetes Care

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 641

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., Putignani, L., Fischer, M., Keller, J. J., Costello, S. P., et al. (2019) · Gut

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 506

Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing

Prodan, A., Tremaroli, V., Brolin, H., Zwinderman, A. H., Nieuwdorp, M., & Levin, E. (2020) · PLOS ONE

Genomics and Phylogenetic StudiesMicrobial Community Ecology and Physiology

Cited by 462

Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health—Pathophysiology and Therapeutic Strategies

Aron-Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M., & Clément, K. (2021) · Gastroenterology

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 452

Role of the Microbiome in Energy Regulation and Metabolism

Nieuwdorp, M., Gilijamse, P. W., Pai, N., & Kaplan, L. M. (2014) · Gastroenterology

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 421

The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial

van Bommel, E. J. M., Muskiet, M. H. A., van Baar, M. J. B., Tonneijck, L., Smits, M. M., Emanuel, A. L., Bozovic, A., Danser, A. H. J., Geurts, F., Hoorn, E. J., et al. (2020) · Kidney International

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 363

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Vacca, M., Kamzolas, I., Harder, L. M., Oakley, F., Trautwein, C., Hatting, M., Ross, T., Bernardo, B., Oldenburger, A., Hjuler, S. T., et al. (2024) · Nature Metabolism

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease

Cited by 262

Microbial modulation of insulin sensitivity

Khan, M. T., Nieuwdorp, M., & Bäckhed, F. (2014) · Cell Metabolism

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 260

Drivers and determinants of strain dynamics following fecal microbiota transplantation

Schmidt, T. S. B., Li, S. S., Maistrenko, O. M., Akanni, W., Coelho, L. P., Dolai, S., Fullam, A., Glazek, A. M., Hercog, R., Herrema, H., et al. (2022) · Nature Medicine

Gut microbiota and healthClostridium difficile and Clostridium perfringens research

Cited by 233

Microbiome-derived ethanol in nonalcoholic fatty liver disease

Meijnikman, A. S., Davids, M., Herrema, H., Aydin, O., Tremaroli, V., Rios-Morales, M., Levels, H., Bruin, S., de Brauw, M., Verheij, J., et al. (2022) · Nature Medicine

Gut microbiota and healthLiver Disease Diagnosis and Treatment

Cited by 215

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

Mózes, F. E., Lee, J. A., Vali, Y., Alzoubi, O., Staufer, K., Trauner, M., Paternostro, R., Stauber, R. E., Holleboom, A. G., van Dijk, A.-M., et al. (2023) · The Lancet Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation

Cited by 214

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study

van Baar, A. C. G., Holleman, F., Crenier, L., Haidry, R., Magee, C., Hopkins, D., Rodriguez Grunert, L., Galvao Neto, M., Vignolo, P., Hayee, B., et al. (2020) · Gut

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 201

Causality of small and large intestinal microbiota in weight regulation and insulin resistance

Scheithauer, T. P. M., Dallinga-Thie, G. M., de Vos, W. M., Nieuwdorp, M., & van Raalte, D. H. (2016) · Molecular Metabolism

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 188

Fecal microbiota transplantation beyond Clostridioides difficile infections

Wortelboer, K., Nieuwdorp, M., & Herrema, H. (2019) · eBioMedicine

Gut microbiota and healthClostridium difficile and Clostridium perfringens research

Cited by 163

Gut Microbiota in Obesity and Undernutrition

de Clercq, N. C., Groen, A. K., Romijn, J. A., & Nieuwdorp, M. (2016) · Advances in Nutrition

Gut microbiota and healthRegulation of Appetite and Obesity

Cited by 140

The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes

Aydin, Ö., Nieuwdorp, M., & Gerdes, V. (2018) · Current Diabetes Reports

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 124

Probiotics, prebiotics, and the host microbiome: the science of translation

Petschow, B., Doré, J., Hibberd, P., Dinan, T., Reid, G., Blaser, M., Cani, P. D., Degnan, F. H., Foster, J., Gibson, G., et al. (2013) · Annals of the New York Academy of Sciences

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 124